However, futile quinone redox cycling can lead to a cascade of ROS formation and as such, the link between toxicity and quinone redox cycling is widely acknowledged 5
OM, INFCP, wisely points out, This treatment works with your bodys systems rather than overriding them. This highlights the importance of a personalized approach tailored to your unique health needs
Presented for research literature review only Gilbert RJ et al
metabolite Ac-LKKTE identified as potentially more active than parent compound Paradoxical finding: Both peptides show biological effects persisting hours to days after administration despite rapid plasma clearance Possible explanations: Tissue retention, active metabolites, or persistent signaling cascade activation Excretion Pathways Limited data exists on excretion for both peptides[22]: Likely renal elimination of peptide fragments Hepatic metabolism may contribute to clearance No accumulation detected in chronic dosing studies (animal models) Combined excretion kinetics have not been characterized in any species The disconnect between short plasma half-lives and prolonged biological effects represents a key area requiring mechanistic clarification for both individual peptides and their combination
Although there have been some promising results much more work needs to be done to confirm dosing ranges and duration of treatment
Research in animal models of traumatic brain injury and stroke shows improved neurological outcomes and reduced lesion volumes following Dihexa treatment, suggesting potential applications in acute neurological injury research